4.3 Article

VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Genetic variation analyses by Pyrosequencing

T Langaee et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)

Letter Pharmacology & Pharmacy

Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype

N Dericioglu et al.

ANNALS OF PHARMACOTHERAPY (2004)